OncologyTube Professional - Patients Click Here
InternationalMyelomaFoundation
92,689 video views
Loading........
Description: In this week’s video, Dr. Brian G.M. Durie explains which criteria and tests determine if a patient’s myeloma is smoldering or active.

BOTTOM LINE:
Only treat myeloma if test results are absolute...
03:58
In this week’s video, Dr. Brian G.M. Durie explains which criteria and tests determine if a patient’s myeloma is smoldering or active. BOTTOM LINE: Only treat myeloma if test results are absolutely clear and show active disease.
03:10
In this week’s video, Dr. Brian G.M. Durie explains that maintenance therapy can prolong remissions and delay relapse. The BOTTOM LINE: If maintenance therapy is well-tolerated, stick with it!
03:58
In this week’s video, Dr. Brian G.M. Durie explains that if you relapse on Darzalex, it is important to carefully discuss all treatment options with your doctor. BOTTOM LINE: If you relapse while on Darzalex, consider all options including upping dosing, new combination therapies, second tran...
03:42
In this week’s video, Dr. Brian G.M. Durie explains why genetic sequencing tests are not yet precise enough to use for choosing myeloma therapies. BOTTOM LINE: We may be able to specify myeloma treatments based on genetic subtypes in the future, but not quite yet!
03:09
In this video, Dr. Brian G.M. Durie explains that second transplant and certain novel therapies may work well for early relapse of myeloma. BOTTOM LINE: Many options are available in cases of early relapse, including second transplant or the use of novel therapy combinations.
03:09
In this week’s video, Brian G.M. Durie explains that even though Revlimid and Pomalyst may reduce white blood cell counts, they do not permanently affect the bone marrow. BOTTOM LINE: Revlimid and Pomalyst may reduce white blood cell counts, so stop or adjust dosing accordingly.
03:55
In this week’s video, Dr. Brian G.M. Durie explains that supplements might have side effects or might interfere with medications for myeloma. BOTTOM LINE: Discuss the use of supplements with your doctor, and do not use supplements as a substitute for myeloma treatment.
04:13
In this week’s video, Dr. Brian G.M. Durie advises that patients discuss with their doctors the many aspects of various treatments, including possible toxicities, cost issues, the patient’s overall health, and the patient’s age. BOTTOM LINE: ​Discuss with your doctor if you should choose a two-d...
03:52
In this week’s video, Dr. Brian G.M. Durie emphasizes the importance of correctly diagnosing and staging myeloma before beginning treatment for the disease. BOTTOM LINE: ​Seek out a myeloma expert to ensure you only begin treatment when absolutely necessary and monitor closely for a definitive d...
04:16
In this week’s video, Dr. Brian G.M. Durie explains that the underlying biology of light chain myeloma is very similar to IgG or IgA myeloma. BOTTOM LINE: ​If you have light chain myeloma, you are not at a higher risk for poorer outcomes than those patients with other types of myeloma.

About InternationalMyelomaFoundation
Description: From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF-TV is your all-access ticket to critical myeloma research, patient education and guidance. Check back often for regularly updated content.

Company: Celebrating its 25th anniversary, the International Myeloma Foundation reaches more than 350,000 members in 120 countries worldwide. A non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses on four key areas: research, education, support, and advocacy. To date, the IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned hotline, and established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. The IMF can be reached at (800) 452-CURE (2873). The global website is www.myeloma.org. Follow the IMF on Twitter @IMFmyeloma.
Links
Channel Url:

Website:


Social Links: